Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 4 Melanoma 2 Sarcoma, Clear Cell 1 Sarcoma 1 Nevus, Blue 1 Neoplasm Metastasis 1 Advanced or Metastatic Solid Tumors 1

Interventions

pembrolizumab 47 Specimen Handling 29 Magnetic Resonance Spectroscopy 25 Biopsy 25 Radiosurgery 17 Gemcitabine 17 Nivolumab 15 Paclitaxel 14 Cyclophosphamide 13 Cisplatin 13 Carboplatin 13 Bevacizumab 12 Drug Therapy 11 Taxes 10 Radiotherapy 10 Oxaliplatin 10 Leucovorin 10 Irinotecan 10 Fluorouracil 10 Capecitabine 10 trastuzumab deruxtecan 8 fludarabine 8 Pemetrexed 8 Doxorubicin 8 Cetuximab 8 cemiplimab 7 abemaciclib 7 Trastuzumab 7 Fulvestrant 7 Docetaxel 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × tebentafusp × Clear all

NCT07057596 2026-03-06

NEO-TB

Grupo Español Multidisciplinar de Melanoma

Phase 2 Recruiting

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡